191 related articles for article (PubMed ID: 25680360)
1. Psychotherapy use in bipolar disorder: Association with functioning and illness severity.
Sylvia LG; Thase ME; Reilly-Harrington NA; Salcedo S; Brody B; Kinrys G; Kemp D; Shelton RC; McElroy SL; Kocsis JH; Bobo WV; Kamali M; McInnis M; Friedman E; Tohen M; Bowden CL; Ketter TA; Singh V; Calabrese J; Nierenberg AA; Rabideau DJ; Elson CM; Deckersbach T
Aust N Z J Psychiatry; 2015 May; 49(5):453-61. PubMed ID: 25680360
[TBL] [Abstract][Full Text] [Related]
2. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
3. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
Deckersbach T; Nierenberg AA; McInnis MG; Salcedo S; Bernstein EE; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; Bobo WV; Friedman ES; Singh V; Tohen M; Bowden CL; Ketter TA; Calabrese JR; Thase ME; Reilly-Harrington NA; Rabideau DJ; Kinrys G; Kamali M
J Clin Psychiatry; 2016 Jan; 77(1):100-8. PubMed ID: 26845265
[TBL] [Abstract][Full Text] [Related]
4. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.
Sylvia LG; Chang WC; Kamali M; Tohen M; Kinrys G; Deckersbach T; Calabrese JR; Thase ME; Reilly-Harrington N; Bobo WV; Kocsis JH; McInnis MG; Bowden CL; Ketter TA; Friedman ES; Shelton RC; McElroy SL; Gao K; Rabideau DJ; Nierenberg AA
J Affect Disord; 2018 Jan; 225():563-568. PubMed ID: 28881294
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy.
Swartz HA; Pilkonis PA; Frank E; Proietti JM; Scott J
Bipolar Disord; 2005 Apr; 7(2):192-7. PubMed ID: 15762861
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum Disorders.
Gao K; Goto T; Yuan C; Brownrigg B; Conroy C; Chan PK; Serrano MB; Ganocy SJ; Fang F; Calabrese JR
J Clin Psychopharmacol; 2018 Oct; 38(5):422-434. PubMed ID: 30102627
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Shesler LW; McElroy SL; Friedman ES; Thase ME; Shelton RC; Bowden CL; Tohen M; Singh V; Deckersbach T; Ketter TA; Kocsis JH; McInnis MG; Schoenfeld D; Bobo WV; Calabrese JR;
Clin Trials; 2014 Feb; 11(1):114-27. PubMed ID: 24346608
[TBL] [Abstract][Full Text] [Related]
8. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
9. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.
Kinrys G; Bowden CL; Nierenberg AA; Hearing CM; Gold AK; Rabideau DJ; Sylvia LG; Gao K; Kamali M; Bobo WV; Tohen M; Deckersbach T; McElroy SL; Ketter TA; Shelton RC; Friedman ES; Calabrese JR; McInnis MG; Kocsis J; Thase ME; Singh V; Reilly-Harrington NA
J Affect Disord; 2019 Mar; 246():126-131. PubMed ID: 30580198
[TBL] [Abstract][Full Text] [Related]
10. Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder.
Wrobel AL; Köhler-Forsberg O; Sylvia LG; Russell SE; Dean OM; Cotton SM; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis MG; Kocsis JH; Friedman ES; Ketter TA; Shelton RC; Ostacher MJ; Iosifescu DV; Berk M; Turner A; Nierenberg AA
Acta Psychiatr Scand; 2022 Jun; 145(6):615-627. PubMed ID: 35243620
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
12. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder.
Miklowitz DJ; Otto MW; Wisniewski SR; Araga M; Frank E; Reilly-Harrington NA; Lembke A; Sachs GS
Psychiatr Serv; 2006 Jul; 57(7):959-65. PubMed ID: 16816280
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.
Köhler-Forsberg O; Sylvia L; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis M; Kocsis JH; Friedman ES; Ketter TA; McElroy S; Shelton RC; Nierenberg AA
Depress Anxiety; 2017 Mar; 34(3):281-290. PubMed ID: 28135023
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
16. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
[TBL] [Abstract][Full Text] [Related]
17. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
[TBL] [Abstract][Full Text] [Related]
19. Use of treatment services in a comparative effectiveness study of bipolar disorder.
Sylvia LG; Iosifescu D; Friedman ES; Bernstein EE; Bowden CL; Ketter TA; Reilly-Harrington NA; Leon AC; Calabrese JR; Ostacher MJ; Rabideau DJ; Thase ME; Nierenberg AA
Psychiatr Serv; 2013 Nov; 64(11):1119-26. PubMed ID: 23945956
[TBL] [Abstract][Full Text] [Related]
20. Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.
Köhler-Forsberg O; Madsen T; Behrendt-Møller I; Sylvia L; Bowden CL; Gao K; Bobo WV; Trivedi MH; Calabrese JR; Thase M; Shelton RC; McInnis M; Tohen M; Ketter TA; Friedman ES; Deckersbach T; McElroy SL; Reilly-Harrington NA; Nierenberg AA
J Affect Disord; 2017 Dec; 223():146-152. PubMed ID: 28755622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
